Outcomes of direct-acting antivirals in patients with HCV decompensated cirrhosis: a systematic review and meta-analysis

Outcomes of direct-acting antivirals in patients with HCV decompensated cirrhosis: a systematic review and meta-analysis

BackgroundDirect-acting antivirals (DAA) are effective for chronic hepatitis C virus (HCV) treatment. However, their impact on overall survival (OS), hepatocellular carcinoma (HCC) occurrence, HCC-free survival, and liver function in patients with HCV decompensated cirrhosis remains uncertain. This...

Full description

Bibliographic Details
Main Authors: Tanawat Jongraksak, Alan Chuncharunee, Pongphob Intaraprasong, Amarit Tansawet, Ammarin Thakkinstian, Abhasnee Sobhonslidsuk
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Medicine
Subjects:
hepatitis C virus
decompensated cirrhosis
direct-acting antiviral agent
overall survival
hepatocellular carcinoma
MELD score
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1295857/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1295857/full

Similar Items